Company: ZLAB
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0001628280-25-008409
Chunk: 64

Company: Zai Lab Ltd
Filing Date: 2025-02-27
Form: 10-K
Item: Item 16
Chunk 64
---
 from issuance of ordinary shares upon public offerings217,350 — — Payment of public offering costs(1,283)— — Employee taxes paid related to settlement of equity awards— (8,802)(7,600)Net cash provided by (used in) financing activities219,267 (6,433)(1,730)Effect of foreign exchange rate changes on cash and cash equivalent— — — Net (decrease) increase in cash and cash equivalents(367,226)(378,668)352,807 Cash, cash equivalents and restricted cash — beginning of the year565,981 944,649 591,842 Cash, cash equivalents and restricted cash — end of the year198,755 565,981 944,649 

F-41

Schedule I — Condensed Financial Information of RegistrantZai Lab Limited Financial Information of Parent CompanyNotes 1.    Schedule I has been provided pursuant to the requirements of Rule 12-04(a) and 5-04(c) of Regulation S-X, which require condensed financial information as to the financial position, changes in financial position and results of operations of a parent company as of the same dates and for the same periods for which audited consolidated financial statements have been presented when the restricted net assets of consolidated subsidiaries exceed 25 percent of consolidated net assets as of the end of the most recently completed fiscal year. 2.    The condensed financial information has been prepared using the same accounting policies as set out in the consolidated financial statements except that the equity method has been used to account for investments in its subsidiaries. For the parent company, Zai Lab Limited records its investments in subsidiaries under the equity method of accounting as prescribed in ASC 323, Investments-Equity Method and Joint Ventures. Such investments are presented on the Condensed Balance Sheets as “Investment in subsidiaries”. Ordinarily under the equity, an investor in an equity method investee would cease to recognize its share of the losses of an investee once the carrying value of the investment has been reduced to nil absent an undertaking by the investor to provide continuing support and fund losses. For the purpose of this Schedule I, the parent company has continued to reflect its share, based on its proportionate interest, of the losses of subsidiaries regardless of the carrying value of the investment even though the parent company is not obligated to provide continuing support or fund losses. 3.    Certain information and footnote disclosures normally included in financial statements prepared in accordance with